Pharma & Biotech - Page 20

AstraZeneca (AZN) has signed a global exclusive licence agreement with Dizal to acquire worldwide rights to develop and commercialise Zegfrovy, also known as sunvozertinib. The deal comprises a $600 million upfront payment

The pharmaceutical distribution sector is undergoing a significant transformation, driven by the need to balance highly targeted delivery models with large-scale operational demands. Modern drug supply chains are increasingly complex, requiring distributors

GSK is preparing to seek FDA accelerated approval for its cancer drug Jemperli after a phase 2 trial delivered a significant clinical win in a high-profile cancer indication. Interim results from the

Insulet Corporation (NASDAQ: PODD), maker of the Omnipod tubeless insulin pump, has announced a global partnership with mental health app Calm to support the emotional wellbeing of people living with diabetes. The

Lupin Pharmaceuticals, the U.S. unit of India-based Lupin Limited, has issued a voluntary recall of more than 2.5 million bottles of prescription eye drops following the discovery of an undisclosed contaminant. The

Pharmaceutical manufacturers are increasingly turning to reusable plastic pallets as pressure mounts to deliver high-value products safely, sustainably, and efficiently. ORBIS Corporation strategic account manager Matt Marchetti says the shift reflects growing

The U.S. Food and Drug Administration has issued a proposed rule that would create a streamlined registration pathway for distributed drug manufacturing establishments operating under a hub-and-spoke model. Under the current regulatory

Hengrui Pharma and Elevar Therapeutics have received a third complete response letter from the FDA for their camrelizumab and rivoceranib combination therapy. The rejection marks more than two years of regulatory setbacks

Lawmakers have introduced the first comprehensive bipartisan legislation to overhaul the 340B Drug Pricing Program since its creation more than three decades ago. US Representatives Jake Auchincloss, Scott Peters, and Dr. John

BioMarin has launched a three-episode video podcast series called “Why Do I Pheel This Way?” aimed at teens living with phenylketonuria, known as PKU. The campaign centres on real conversations about the